Reorganization Boosts Headcount of Celera’s Proteomics Group
As part of its reorganization announced last week, Celera has made several changes to the proteomics operation at its Rockville, Md., headquarters, a spokesman said. Specifically, a group of scientists formerly involved in an effort to develop therapeutic vaccines will be redeployed to the proteomics group, to bolster its capabilities in cell biology.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
